METAVIA INC. Stock Split Ratio
METAVIA INC. (MTVA) reported Stock Split Ratio of 9.10% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2026-03-26
- METAVIA INC. stockholders' equity note, stock split, conversion ratio for fiscal 2025 was 9.10%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month |
|---|---|---|---|
| 2025-12-31 | 9.10% 10-K · filed 2026-03-26 | ||
| 2023-12-31 | 13.00% 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | 13.00% 10-Q · filed 2024-11-07 | ||
| 2022-09-30 | 3.00% 10-K · filed 2024-03-28 | ||
| 2022-09-12 | 33.00% 10-Q · filed 2023-08-09 | ||
| 2019-08-11 | 0.01% 10-K · filed 2021-04-15 | ||
| 2016-04-30 | 32.06% 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |